American Century Companies’s Centessa Pharmaceuticals CNTA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $14.9M | Buy |
1,130,708
+37,954
| +3% | +$499K | 0.01% | 1219 |
|
2025
Q1 | $15.7M | Buy |
1,092,754
+13,046
| +1% | +$188K | 0.01% | 1141 |
|
2024
Q4 | $18.1M | Sell |
1,079,708
-59,838
| -5% | -$1M | 0.01% | 1101 |
|
2024
Q3 | $18.2M | Buy |
1,139,546
+204,395
| +22% | +$3.27M | 0.01% | 1064 |
|
2024
Q2 | $8.44M | Buy |
935,151
+12,031
| +1% | +$109K | 0.01% | 1312 |
|
2024
Q1 | $10.4M | Buy |
923,120
+47,355
| +5% | +$535K | 0.01% | 1189 |
|
2023
Q4 | $6.97M | Buy |
875,765
+180,880
| +26% | +$1.44M | ﹤0.01% | 1293 |
|
2023
Q3 | $4.5M | Buy |
694,885
+23
| +0% | +$149 | ﹤0.01% | 1370 |
|
2023
Q2 | $4.3M | Buy |
694,862
+180,746
| +35% | +$1.12M | ﹤0.01% | 1359 |
|
2023
Q1 | $1.97M | Sell |
514,116
-312
| -0.1% | -$1.2K | ﹤0.01% | 1614 |
|
2022
Q4 | $1.59M | Sell |
514,428
-1,318
| -0.3% | -$4.09K | ﹤0.01% | 1638 |
|
2022
Q3 | $2.07M | Sell |
515,746
-1,831
| -0.4% | -$7.36K | ﹤0.01% | 1435 |
|
2022
Q2 | $2.52M | Buy |
517,577
+342
| +0.1% | +$1.67K | ﹤0.01% | 1340 |
|
2022
Q1 | $4.64M | Buy |
517,235
+112
| +0% | +$1.01K | ﹤0.01% | 1126 |
|
2021
Q4 | $5.82M | Buy |
517,123
+146,831
| +40% | +$1.65M | ﹤0.01% | 1010 |
|
2021
Q3 | $6.18M | Sell |
370,292
-1,212
| -0.3% | -$20.2K | ﹤0.01% | 976 |
|
2021
Q2 | $8.25M | Buy |
+371,504
| New | +$8.25M | 0.01% | 875 |
|